17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one,
745, GG,
Avodart,
dutasteride,
GG 745,
GG-745,
GG745,
GI198745,
Dutasteride,
164656-23-9,
Avodart,
GG-745,
GG 745,
GI 198745,
GI-198745,
UNII-O0J6XJN02I,
GI198745,
O0J6XJN02I,
CHEMBL1200969,
Avolve,
CHEBI:521033,
Dutasteride, 99%,
(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide,
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide,
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(2,5-Bis(trifluoromethyl)phenyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide,
alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide,
C27H30F6N2O2,
Duagen,
(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide,
Avodart (TN),
Avidart,
Dutasteride (JAN/USAN/INN),
Dutasteride [USAN:INN:BAN],
NCGC00164571-01,
1H-Indeno(5,4-f)quinoline-7-carboxamide, N-(2,5-bis(trifluoromethyl)phenyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-,
1H-Indeno[5,4-f]quinoline-7-carboxamide, N-[2,5-bis(trifluoromethyl)phenyl]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-,
GI-198745X,
AC1OCF98,
SCHEMBL5903,
DSSTox_CID_26452,
DSSTox_RID_81626,
DSSTox_GSID_46452,
GTPL7457,
DTXSID8046452,
Dutasteride, >=98% (HPLC),
AOB5568,
JWJOTENAMICLJG-QWBYCMEYSA-N,
BCPP000248,
BCP02344,
EX-A1952,
ZINC3932831,
Tox21_112199,
BDBM50340481,
MFCD00937869,
NSC740477,
s1202,
AKOS015920136,
AKOS015924431,
BCP9000630,
CS-1542,
DB01126,
GS-3565,
MCULE-1602474627,
NSC-740477,
RL02115,
N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide,
BR-72895,
CC-27419,
HY-13613,
SC-08812,
AB1009276,
CAS-164656-23-9,
FT-0080365,
ST24026289,
B-2151,
D03820,
J10036,
AB01274774-01,
AB01274774_02,
656D239,
C-23099,
Q-201052,
BRD-K30373883-001-02-8,
Z1563146168,
Dutasteride, European Pharmacopoeia (EP) Reference Standard,
Dutasteride, United States Pharmacopeia (USP) Reference Standard,
(5|A,17|A)-N-{2,5-Bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-l-ene-17-carboxamide,
Dutasteride for system suitability, European Pharmacopoeia (EP) Reference Standard,
(1S,2R,7R,10S,11S,14S,15S)-N-[2,5-bis(trifluoromethyl)phenyl]-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-3-ene-14-carboxamide,
(5.alpha.,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide;dutasteride;Avodart;,
(5alpha,17beta)-N-{2,5-bis(trifluoromethyl)-phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide,
veltride,
Dutasteride [USAN],
Avidart (TN),
Duprost (TN),
Dutagen (TN),
Avodart, Dutasteride,
Avolve (TN),
Duagen (TN),
Dutas (TN),
D0A9YA,
Dutasteride(forbidden drug),
Dutasteride [USAN:INN:JAN],
GG745,
2-Hydroxy-4-trifluoromethylpyrimidine,
745, GG,
ACN-046785,
C27-H30-F6-N2-O2,
CID6918296,
CS-O-30894,
C108373,
D000068538,
17-beta-N-[2,5-Bis(trifluoromethyl)phenyl]carbamoyl-4-aza-5-alpha-androst-1-en-3-one,
17beta-N-(2,5-bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one,
(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide,
(5-alpha,17-beta)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide,
1h-indeno[5,4-f]quinolina-7-carboxamida, n-[2,5-bis(trifluorometil)fenil]-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahidro-4a,6a-dimetil-2-oxo-, (4ar,4bs,6as,7s,9as,9bs,11ar)-,